reglab/statecodes huggingface dataset:
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 10 - Human Substance Abuse Testing › Section 10-3 - Reasonable suspicion selection

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC 4-31
Sec. 3.
(a)
				Applicants for a license or a licensee may be selected at any time while within
				the enclosure for testing on a reasonable suspicion basis.
(b) Reasonable suspicion. When determining
				whether there is reasonable suspicion to require testing, the judges may
				consider, but are not limited to, any of the following factors:
(1) Unexplained or continued rule violations
				which have a detrimental effect on racing.
(2) Involvement in any accident which causes
				injury to person or animal at the track as well as any near accident which
				created a clear danger of accident or injury to person or animal at the
				track.
(3) Willful conduct
				detrimental to horse racing as evidenced by continued rule violations, other
				disciplinary problems, behavioral problems, disturbances, or other similar
				conduct at the track.
(4)
				Observable physical or emotional impairment at the track.
(5) Involvement in a race of questionable
				outcome or circumstance as determined by the judges in the exercise of their
				expertise.
(6) Willful abuse of
				animal or person who is engaged in a race, work, or exercise at the
				track.
(7) Prior positive test or
				tests in this or other jurisdictions, excluding those where a valid legal
				prescription has been revealed.
(8)
				Performance of prescribed duties in a manner which indicates a best effort to
				win is not present at the track.
(9) Information supplied by:
(A) a law enforcement agency;
(B) the USTA;
(C) the ARCI; or
(D) the horse racing commission of any state
				or country; which is verified in writing relating to drug or alcohol abuse, or
				both.
(10) Any other
				physical conduct at the track which can be documented which would indicate
				reasonable grounds to believe the existence of, dependence on, possession of,
				or usage of:
(A) a controlled substance;
				or
(B) an alcohol
				violation.
(11) Refusal
				to provide a urine or saliva sample when requested to do so within this
				section.
(12) Recent arrest or
				pending criminal charges regarding the sale, possession, manufacture,
				cultivation, or use of illegal drugs.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 10 - Human Substance Abuse Testing › Section 10-4 - Taking of samples

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC 4-31
Sec. 4.
Any applicant or licensee selected by direction of the
				  judges, commission personnel, or their designee, who is requested to submit to
				  a urine or saliva test shall, without undue delay, at a location and in the
				  manner prescribed by the commission provide the urine or saliva sample, or
				  both.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 10 - Human Substance Abuse Testing › Section 10-5 - Positive sample results

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC 4-31
Sec. 5.
(a) A
				positive test result attained shall be reported in writing to the commission
				director of security or his or her designee from the laboratory performing the
				test analysis. A positive test result confirming the presence of any controlled
				substance or prescription drugs shall be prima facie evidence that there has
				been a violation of section 1 of this rule. In the event of such a positive
				test, it is presumed that:
(1) the sample of
				urine or saliva tested by the laboratory to which it is sent is taken from the
				person and its integrity has been preserved;
(2) all accompanying procedures of
				collection, preservation, transfer to the laboratory, and analysis of the
				sample are correct and accurate; and
(3) the report received from the laboratory
				pertains to the sample taken from the person in question and correctly reflects
				the condition of the person at the time that the sample was given.
With respect to the presumptions set forth in this
				  subsection, the burden is on the person against whom the test is offered to
				  prove otherwise at any hearing in regard to the matter which is conducted by
				  the judges or by the commission.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 10 - Human Substance Abuse Testing › Section 10-6 - Penalties

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC 4-31
Sec. 6.
(a) Upon a
				finding of a positive test, the judges or commission shall, to the extent of
				its regulatory authority, impose the following sanctions:
(1) For a licensee's first violation, he or
				she shall be suspended for thirty (30) days and, in order for the suspension to
				be lifted, shall be subject to a mandatory drug retest after thirty (30) days
				from the first violation of this article. Such additional drug test, known as
				the standard drug test, shall be done by the commission testing laboratory at
				the licensee's expense. Until such retest using the standard drug test achieves
				negative results, the licensee shall remain suspended with the following
				exceptions:
(A) For a licensee's first
				violation, he or she may take a drug test after thirty (30) days from the first
				violation of this article known as the immediate drug test. Provided the
				immediate drug test is negative, the licensee's suspension will be lifted, by
				amending the initial ruling, while the results of the standard drug test are
				pending. If the licensee's standard drug test returns a negative result, the
				licensee's suspension remains lifted.
(B) If the standard drug test returns a
				positive result, the judges will enter an amended ruling suspending the
				licensee until such time as a standard drug test, which shall be done by the
				commission testing laboratory at the licensee's expense, returns a negative
				result.
The licensee is only allowed one (1) immediate drug test,
				  which is to be taken at the end of the initial thirty (30) day
				  suspension.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 11 - Prohibition of Alcohol › Section 11-1 - Prohibited use or presence of alcohol within the enclosure

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-8-4
Sec. 1.
(a) No
				racing official or driver during or prior to the performance of his or her
				duties shall consume any alcoholic beverage within the enclosure of any race
				track under the control of the commission.
(b) No racing official, driver, trainer,
				groom, or other licensee attending to horses or within a restricted area of any
				race track under the control of the commission shall have present within his or
				her body any amount of alcohol in excess of five-hundredths of one percent
				(.05%) by weight in grams in one hundred (100) milliliters of the person's
				blood, or in two hundred ten (210) liters of the person's breath.
(c) The fact that any person charged with a
				violation of this rule is or has been otherwise lawfully entitled to use or
				consume an alcoholic beverage shall not constitute a defense against any charge
				of violating this rule.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 11 - Prohibition of Alcohol › Section 11-2 - Licensee subject to testing; positive sample results

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-8-4
Sec. 2.
A permit holder shall provide an alcohol breath testing
				  device that is approved by the commission and operated by a person certified to
				  use such a device. All drivers, judges, starters, the paddock judge, horse
				  identifier, photo finish technician, test barn veterinarian, racing
				  veterinarian, outriders, and drivers of starting gates shall submit to a breath
				  test prior to the beginning of their duties at each program in which they
				  participate. Any licensee on the track surface during training hours or any
				  licensee scheduled to drive in a qualifying race is subject to testing at the
				  discretion of the judges. In addition, the racing secretary, the judges, the
				  commission director of security, or the track chief of security may order a
				  licensee to submit to a breath test at any time there is reason to believe the
				  licensee may have consumed sufficient alcohol to cause the licensee to fail a
				  breath test. A positive test result as defined by section 1(b) of this rule
				  shall be prima facie evidence that there has been a violation of of
[sic]
section 1 of this rule. In the event of such positive
				  test, it is presumed that:
(1) the
				breath sample tested is taken from the person and its integrity has been
				preserved;
(2) all accompanying
				procedures of collection and analysis of this sample are correct and accurate;
				and
(3) the report issued by the
				commission pertains to the sample taken from the person in question correctly
				reflects the condition of the person at the time of the sample was given.
With respect to the presumptions set forth in this section,
				  the burden is on the person against whom the test is offered to prove otherwise
				  at any hearing in regard to the matter which is conducted by the stewards or by
				  the commission.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 11 - Prohibition of Alcohol › Section 11-3 - Penalties

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-8-4; IC
				  4-31-13
Sec. 3.
(a) A person
				whose breath test shows a reading of more than five-hundredths of one percent
				(0.05%) by weight of alcohol in the person's breath or blood shall be summarily
				suspended under the rules of the commission and subject to any other sanction
				available to the commission pursuant to the provisions of IC
				4-31-13.
(b) The judges may relieve a licensee, except
				an owner, owner/trainer, or trainer, of any duties for that day should that
				person show a reading between one-hundredth of one percent (0.01%) and
				five-hundredths of one percent (0.05%) by weight of alcohol in a person's
				blood.
(c) The permit holder's
				security department shall immediately inform the judges of any reading of
				one-hundredth of one percent (0.01%) and above.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 11 - Prohibition of Alcohol › Section 11-4 - Refusal or failure to be tested

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-8-4
Sec. 4.
The judges may, on behalf of the commission, impose the
				  following sanctions against a licensee who refuses or fails to submit to or
				  complete a breath test:
(1) For the
				first refusal or failure, a civil penalty of one hundred dollars ($100) and a
				seven (7) day suspension.
(2) For a
				second refusal or failure, a civil penalty of two hundred fifty dollars ($250)
				and a thirty (30) day suspension.
(3) For any additional refusals or failures
				to submit to a breath test, a civil penalty of two hundred fifty dollars
				($250), a sixty (60) day suspension, and referral of the case to the commission
				for any further action that the commission considers necessary.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 13 - Equine Health; Requirements › Section 13-1 - Equine health; requirements

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC 4-31
Sec. 1.
(a) Any
				horse stabled on the grounds, participating in a race, or entered in a race
				shall have on file with the association prior to entering the association
				premises a negative test result for equine infectious anemia (Coggins test)
				within the last twelve (12) months, in accordance with state law.
(b) Any horse entering association grounds
				that is arriving from out of state, and entering association grounds for the
				first time after racing or residing in a state other than Indiana for any
				period of time, shall have on file with the racing secretary prior to entering
				the association premises a certificate of veterinary inspection (CVI or health
				certificate) completed within the last thirty (30) days by a licensed
				veterinarian, in accordance with state law.
(c) A copy of all documents described in
				subsections (a) and (b) and any additional documentation required by the
				association shall be kept with the horse at all times and presented to security
				personnel upon entering association premises.
(d) Any person found altering,
				counterfeiting, or forging any document including, but not limited to, proof of
				equine infections anemia (Coggins test), certificate of veterinary inspection
				(CVI or health certificate), or any other additional documentation required by
				the association in an attempt to circumvent these rules shall be subject to a
				fine or suspension or both.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-1 - Medication

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 1.
(a) No horse
				participating in a race or entered in a race shall carry in its body any
				foreign substance as defined in 71 IAC 1.5, except as provided for in this
				rule.
(b) No substance, foreign or
				otherwise, shall be administered to a horse entered to race by:
(1) injection;
(2) jugging;
(3) oral administration;
(4) tube;
(5) rectal infusion or suppository;
(6) inhalation; or
(7) any other means;
within twenty-four (24) hours prior to the scheduled post
				  time for the first race except furosemide as provided for in this rule. The
				  prohibitions in this section include, but are not limited to, injection or
				  jugging of vitamins, electrolyte solutions, and amino acid solutions. The
				  prohibition also includes, but is not limited to, the administration of
				  breathing compounds for oral and nasal dosing, such as Traileze, Vapol, Vicks
				  vapor-rub, wind-aid, exhale ease, or containing methylsalicylate, camphor, or
				  potassium iodide.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-1.5 - Medication

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-2.1; IC
				  4-31-12
Sec. 1.5.
(a) No
				horse participating in a race or entered in a race shall carry in its body any
				foreign substance as defined in 71 IAC 1
[71 IAC 1.5]
or IC
				4-31-2.1, except as provided for in
				this rule.
(b) No substance,
				foreign or otherwise, shall be administered to a horse entered to race by:
(1) injection;
(2) jugging;
(3) oral administration;
(4) tube;
(5) rectal infusion or suppository;
(6) inhalation; or
(7) any other means;
within twenty-four (24) hours prior to the scheduled post
				  time for the first race except furosemide, as provided for in this rule. The
				  prohibitions in this section include, but are not limited to, injection or
				  jugging of vitamins, electrolyte solutions, and amino acid solutions. The
				  prohibition also includes, but is not limited to, the topical, oral, or nasal
				  administration of compounds, such as Traileze, Vapol, Vicks vapor-rub,
				  wind-aid, exhale ease, or containing methylsalicylate, camphor, potassium
				  iodide, or products containing "caine" derivatives or dimethylsulfoxide
				  (DMSO).
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2 - Foreign substances prohibited

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 2.
(a) No horse
				participating in a race shall carry in its body any foreign substance except as
				provided by these rules. A finding by the chemist or commission designee that a
				foreign substance is present in the test sample shall be prima facie evidence
				that such foreign substance was administered and carried in the body of the
				horse while participating in a race. Such a finding shall also be taken as
				prima facie evidence that the trainer and his or her agents responsible for the
				care or custody of the horse have been negligent in the handling or care of the
				horse.
(b) Upon a finding of a
				violation of this section, the owners or lessees of the horse from which the
				specimen was obtained shall forfeit any purse money and any trophy or award.
				However, forfeiture of any purse, trophy, or award for an overage of
				phenylbutazone, flunixin, ketoprofen, or furosemide in violation of these rules
				shall be consistent with Recommended Penalties of the Association of Racing
				Commissioners, International, as revised by the ARCI in 2014 and any other
				subsequent revision effective after said date, which are incorporated by
				reference herein, copies of which are available at the commission office.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2.1 - Clenbuterol prohibited in quarter horses

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 2.1.
(a) No
				quarter horse participating in a race shall carry in its body clenbuterol. A
				finding by the chemist or commission designee that clenbuterol is present in
				the test sample shall be prima facie evidence that clenbuterol was administered
				and carried in the body of the horse while participating in a race. Such a
				finding shall also be taken as prima facie evidence that the trainer and his or
				her agents responsible for the care or custody of the horse have been negligent
				in the handling or care of the horse.
(b) Upon a finding of a violation of this
				section, whether by pre-race testing or post-race testing, the owners or
				lessees of the horse from which the sample was obtained shall forfeit any purse
				money and any trophy or award resulting from the associated race. If the purse
				money, trophy, or award is associated with a qualifying race, a positive test
				for clenbuterol shall render the horse ineligible for any subsequent related
				race.
(c) In the event a sample
				from a quarter horse results in a finding of clenbuterol, the quarter horse
				shall be placed on the veterinarian's list as provided in
				71 IAC 8.5-8-1.5.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2.2 - Albuterol prohibited in quarter horses

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 2.2.
(a) No
				quarter horse participating in a race shall carry in its body albuterol in
				excess of the threshold provided in section 4.2(2) of this rule. A finding by
				the chemist or commission designee that albuterol in excess of the threshold is
				present in the test sample shall be prima facie evidence that albuterol was
				administered and carried in the body of the horse while participating in a
				race. Such a finding shall also be taken as prima facie evidence that the
				trainer and his or her agents responsible for the care or custody of the horse
				have been negligent in the handling or care of the horse.
(b) Upon a finding of a violation of this
				section, whether by pre-race testing or post-race testing, the owners or
				lessees of the horse from which the specimen was obtained shall forfeit any
				purse money and any trophy or award. If the purse money, trophy, or award is
				associated with a qualifying race, a positive test for albuterol shall render
				the horse ineligible for any subsequent related race.
(c) In the event a sample from a quarter
				horse results in albuterol in excess of the threshold, the quarter horse shall
				be placed on the veterinarian's list as provided in
				71 IAC 8.5-8-1.5.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2.3 - Other beta-agonist drugs

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 2.3.
Any horse that is the subject of a positive test report from
				  a commission approved equine drug testing laboratory for any beta-agonist
				  drugs, other than clenbuterol and albuterol, with anabolic effects that are not
				  currently Penalty Class A drugs, as provided in the most recent version of the
				  ARCI Uniform Classification Guidelines for Foreign Substances and Recommended
				  Penalties Model Rule, shall be placed immediately on the veterinarian's list as
				  provided in
				  71 IAC
				  8.5-8-1.6.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2.4 - Clenbuterol prohibited in thoroughbred horses entered to race

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 2.4.
(a) No
				thoroughbred participating in a race shall carry in its body clenbuterol. A
				finding by the chemist or commission designee that clenbuterol is present in
				the test sample shall be prima facie evidence that clenbuterol was administered
				and carried in the body of the horse while participating in a race. Such a
				finding shall also be taken as prima facie evidence that the trainer and his or
				her agents responsible for the care and custody of the horse have been
				negligent in the handling or care of the horse.
(b) Upon a finding of a violation of this
				section, whether by pre-race testing or post-race testing, the owners or
				lessees of the horse from which the sample was obtained shall forfeit any purse
				money and any trophy or award resulting from the associated race.
(c) In the event a sample from a thoroughbred
				results in a finding of clenbuterol, the thoroughbred shall be placed on the
				veterinarian's list as provided in
				71 IAC 8.5-8-1.3.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-2.5 - Thyroxine restricted

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 2.5.
(a)
				Thyroid supplementation is prohibited. Trainers shall not have thyroxine, any
				other thyroid hormone, thyroid hormone analog, or thyroid supplements on the
				premise of a facility under the jurisdiction of the commission, nor shall they
				administer such supplements unless both of the following conditions have been
				met:
(1) A thyrotropin-releasing hormone
				(TRH) response test has been performed by a commission-licensed veterinarian
				and supports a diagnosis of hypothyroidism in the horse.
(2) A commission-licensed veterinarian has
				submitted the TRH response test result to the equine medical director, and the
				equine medical director approves the thyroxine prescription based on their
				independent determination that the test result confirms the hypothyroidism
				diagnosis.
A T3 or T4 test without stimulation of the thyroid is
				  insufficient to diagnose hypothyroidism.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-3 - Foreign substances allowed

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 3.
Furosemide, when used in accordance with the test levels and
				  guidelines set forth in sections
[sic, section]
5 of this
				  rule, is a permitted foreign substance for race day
				  administration.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-4.1 - Nonsteroidal anti-inflammatory drugs (NSAIDs)

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 4.1.
(a) The
				use of nonsteroidal anti-inflammatory drugs (NSAIDs) shall be governed by the
				following conditions:
(1) NSAIDs included in
				the ARCI Controlled Therapeutic Medication Schedule for Horses, as revised by
				the ARCI in December 2019 and any other subsequent revision effective after
				said date, which are incorporated by reference herein, copies of which are
				available at the commission office, are not to be used in a manner inconsistent
				with the restrictions contained therein. NSAIDs not included on the ARCI
				Controlled Therapeutic Medication Schedule for Horses are not permitted to be
				present in a biological sample at a concentration that equals or exceeds the
				commission's official laboratory's limit of detection.
(2) Biological samples may contain one (1) of
				the NSAIDs identified in the ARCI Controlled Therapeutic Medication Schedule
				for Horses at a concentration up to the primary threshold indicated therein.
				The presence of more than one (1) NSAID in blood or urine, or both, shall
				constitute an NSAID stacking violation (Penalty Class B) in addition to the
				violation associated with the detection of each additional NSAID that exceeds
				the primary threshold.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-4.5 - Corticosteroids, stacking violations, and intra-articular injection restrictions

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 4.5.
(a) The
				use of corticosteroids shall be governed by the following conditions:
(1) Corticosteroids included in the ARCI
				Controlled Therapeutic Medication Schedule for Horses, as revised by the ARCI
				in December 2019 and any other subsequent revision effective after said date,
				which are incorporated by reference herein, copies of which are available at
				the commission office, are not to be used in a manner inconsistent with the
				restrictions contained therein. Corticosteroids not included in the ARCI
				Controlled Therapeutic Medication Schedule for Horses are not to be present in
				a biological sample at a concentration that equals or exceeds the commission's
				official laboratory's limit of detection.
(2) Biological samples may contain one (1) of
				the corticosteroids identified in the ARCI Controlled Therapeutic Medication
				Schedule for Horses at a concentration up to the threshold level indicated
				therein; the presence of more than one (1) corticosteroid in blood or urine, or
				both, shall constitute a corticosteroid stacking violation (Penalty Class B) in
				addition to the violation associated with the detection of each additional
				corticosteroid that exceeds the threshold level.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-5 - Furosemide as a permitted foreign substance

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 5.
(a)
				Furosemide may be administered intravenously to a horse that is entered to
				compete in a race under the following conditions:
(1) The horse's licensed trainer, or a
				licensed veterinarian, determines that it would be in the horse's best
				interests to race with furosemide.
(2) Notice that a horse eligible to race on
				furosemide will race, with or without furosemide, shall be made at the time of
				entry to ensure public notification, including publication in the official
				racing program.
(3) If a horse's
				licensed trainer, or a licensed veterinarian, determines that it is no longer
				in the horse's best interests to race with furosemide, the horse shall not be
				eligible to receive furosemide unless the licensed trainer, or a licensed
				veterinarian, later determines that it would be in the horse's best interests
				to resume furosemide treatments for racing, and the licensed trainer or
				licensed veterinarian complies with the requirements of this section.
(4) Furosemide shall only be administered on
				association grounds.
(5) Upon the
				request of the commission or its designee, the veterinarian administering
				furosemide shall surrender the syringe used to administer such medication,
				which may then be submitted for testing.
(6) A horse eligible to receive furosemide
				must be treated at least four (4) hours, and not more than four (4) hours and
				twenty-five (25) minutes, prior to the scheduled post time of its
				race.
(7) Furosemide shall be
				administered by a veterinarian licensed by the commission at an intravenous
				dose level not to exceed five hundred (500) milligrams and not less than one
				hundred fifty (150) milligrams. Administration of furosemide shall take place
				in the test barn or a specific location otherwise designated by the commission.
				An association employee shall be present and observe the drawing of furosemide
				into a syringe. The administering veterinarian shall provide a factory sealed
				bottle of furosemide from which the draws shall be made. The association shall
				establish track rules for furosemide administrations that are consistent with
				these regulations.
(8) The test
				level of furosemide under this rule shall not be in excess of one hundred (100)
				nanograms per milliliter of serum or plasma and shall not be below a urine
				specific gravity of one and ten one-thousandths (1.010). If an insufficient
				volume of urine is obtained, a positive test shall be based upon quantitative
				testing performed on blood serum or plasma only. Split sample testing shall be
				quantitative and be performed on blood serum or plasma only.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-5.5 - Bleeding from nostrils

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 5.5.
A horse known to have bled from its nostrils for the first
				  time within a three hundred sixty-five (365) day period during a race or
				  workout may not be entered or raced during the next fourteen (14) days without
				  prior approval for racing by the official veterinarian or his/her designee. If
				  a horse bleeds from its nostrils a second time within a three hundred
				  sixty-five (365) day period, the horse shall be placed on the veterinarian's
				  list and prohibited from racing for thirty (30) days. If a horse bleeds from
				  its nostrils a third time within a three hundred sixty-five (365) day period,
				  the horse shall be placed on the veterinarian's list and prohibited from racing
				  for at least one hundred eighty (180) days. A horse that bleeds from its
				  nostrils, but upon endoscopic examination shows no sign of pulmonary
				  hemorrhage, shall not be subject to the restrictions imposed by this section.
				  The horse may be removed from the veterinarian's list by the official
				  veterinarian after a satisfactory workout. If a horse bleeds from its nostrils
				  a fourth time, the horse is prohibited from racing in
				  Indiana.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-5.6 - Anti-ulcer medications

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 5.6.
The following anti-ulcer medications are permitted to be
				  administered, at the stated dosage, up to twenty-four (24) hours prior to the
				  race in which the horse is entered:
(1) Cimetidine (Tagamet®) - 8-20 mg/kg PO
				BID-TID
(2) Omeprazole
				(Gastrogard®) - 2.2 grams PO SID
(3) Ranitidine (Zantac®) - 8 mg/kg PO
				BID
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-6 - Program information

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 6.
In order to inform the race track patrons of those horses
				  racing with medication, the permit holder shall indicate in the racing program
				  that a horse is racing with permitted foreign substances for race day
				  administration.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-7 - Drug classification and penalties

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 7.
(a) Except
				as provided in subsection (b), upon a finding of a violation of this rule, the
				stewards shall consider the classification level of the violation as currently
				established by the Uniform Classification Guidelines of Foreign Substances and
				Recommended Penalties and Model Rule as revised by the ARCI in August 1996 and
				any other subsequent revision effective after said date, which are incorporated
				by reference herein, and impose penalties and disciplinary measures consistent
				with the recommendations contained therein. Provided, however, that in the
				event a majority of the stewards determine that mitigating circumstances
				require imposition of a lesser penalty they may impose the lesser penalty. In
				the event a majority of the stewards wish to impose a greater penalty or a
				penalty in excess of the authority granted them, then, and in such event, they
				may impose the maximum penalty authorized and refer the matter to the
				commission with specific recommendations for further action.
(b) Cobalt shall carry a category "B"
				penalty, as established by the Recommended Penalties and Model Rule, regardless
				of its presence in a post-race or out of competition sample. The stewards shall
				consider levels less than fifty (50) parts per billion a mitigating factor and
				levels of one hundred (100) parts per billion or more an aggravating factor
				when determining penalties.
NOTE: Expiration postponed by Executive Order #13-27,
					 posted at 20140108-IR-GOV130576EOA.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-8 - Androgenic-anabolic steroids (AAS)

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 8.
(a) No AAS
				(androgenic-anabolic steroid) shall be permitted in test samples collected from
				racing horses except for endogenous concentrations of the naturally occurring
				substances boldenone, nandrolone, and testosterone at concentrations less than
				the indicated thresholds.
(b)
				Concentrations of these AAS shall not exceed the following urine threshold
				concentrations for total (i.e., free drug or metabolite and drug or metabolite
				liberated from its conjugates) steroid:
(1)
				Boldenone:
(A) In male horses other than
				geldings - fifteen (15) ng/mL of urine.
(B) In geldings, fillies, and mares - one (1)
				ng/mL of urine.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 1 - Rule1Equine Health; Medication Rules › Section 1-9 - Environmental contaminants and substances of human use

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 9.
(a)
				Substances described in subsection (b) are recognized as either:
(1) environmental containments
[sic]
in that they are endogenous to the horse or that they
				can arise from plants traditionally grazed or harvested as equine feed or are
				present in equine feed because of contamination during cultivation, processing,
				treatment, storage, or transportation phases; or
(2) substances of human use and addiction and
				which could be found in the horse due to its close association with
				humans.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 2 - Drug Testing › Section 2-1 - Laboratory reports

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 1.
A finding by a chemist at a commission-approved equine drug
				  testing laboratory that a test sample taken from a horse contains a drug or its
				  metabolites or analogs, or any substance foreign to the natural horse, any drug
				  found in excess of the commission-approved levels, substances present in the
				  horse in excess of concentrations at which such substances could occur
				  naturally, or substances foreign to a horse at concentrations that cause
				  interference with testing procedures shall be prima facie evidence that such
				  foreign substance has been administered to the horse either internally or
				  externally in violation of this rule. It is presumed that:
(1) the sample of urine, saliva, blood, hair,
				or other acceptable specimen tested by the approved laboratory to which it is
				sent is taken from the horse in question, its integrity is preserved;
(2) all accompanying procedures of
				collection, preservation, transfer to the laboratory, and analysis of the
				sample are correct and accurate; and
(3) the report received from the laboratory
				pertains to the sample taken from the horse in question and correctly reflects
				the condition of the horse during the race in which it was entered or, in a
				case of out of competition testing, when the test sample was taken;
with the burden on the trainer, assistant trainer, or other
				  responsible person to prove otherwise at any hearing in regard to the matter
				  conducted by the stewards or the commission.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 2 - Drug Testing › Section 2-2 - Pre-race testing

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 2.
The stewards may require any horse entered to race to submit
				  to a blood or other pre-race test, and no horse is eligible to start in a race
				  until the owner or trainer complies with the required testing
				  procedure.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 2 - Drug Testing › Section 2-3 - Selection of horses tested

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 3.
(a) The
				stewards, the official veterinarian or his/her designee, a licensed
				veterinarian authorized by the commission, a member of the commission, or the
				executive director of the commission may order a blood test, hair test, or
				urine test, or all three (3), on a horse for the purpose of analysis.
(b) A blood specimen, hair specimen, or urine
				specimen, or all three (3), shall be taken from the following horses after the
				running of each race:
(1) The horse that
				finishes first in each race.
(2)
				Any other horses designated by the stewards, the official veterinarian or
				his/her designee, a licensed veterinarian authorized by the commission, a
				member of the commission, or the executive director of the
				commission.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 2 - Drug Testing › Section 2-4 - Taking of samples

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 4.
(a) Blood,
				urine, saliva, hair, or other samples shall be:
(1) taken under the direction of the official
				veterinarian or persons appointed or assigned by the official veterinarian for
				such purposes;
(2) taken in a
				detention area approved by the commission unless the official veterinarian or
				stewards approves otherwise;
(3)
				witnessed, confirmed, or acknowledged by the trainer of the horse being tested
				or his or her authorized representative or employee and may be witnessed by the
				owner, trainer, or other licensed person designated by them;
(4) sent to racing laboratories approved and
				designated by the commission in such manner as the commission or its designee
				may direct; and
(5) in the custody
				of the official veterinarian, his or her assistants, or other persons approved
				by the executive director or the official veterinarian from the time they are
				taken until they are delivered for shipment to the testing laboratory.
No person shall tamper with, adulterate, add to, break the
				  seal of, remove, or otherwise attempt to so alter or violate any sample
				  required to be collected by this rule, except for the addition of preservatives
				  or substances necessarily added by the commission approved laboratory for
				  preservation of the sample or in the process of analysis.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 2 - Drug Testing › Section 2-5 - Out of competition testing

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 5.
(a) Any
				horse eligible to race in Indiana under this subsection is subject to testing
				without advance notice for prohibited substances, practices, and procedures as
				specified in subsection (f), while the horse is located on the grounds of a
				racetrack under the jurisdiction of the commission, or stabled off association
				grounds while under the care or control of a trainer or owner licensed by the
				commission under the restrictions listed in subsection (e). A horse is eligible
				to race in Indiana if it is listed:
(1) on an
				owner's or trainer's license application;
(2) on a stall application or nomination
				list; or
(3) on the horse sign-in
				sheet at any time during the meet;
or has raced at any Indiana race meet during the preceding
				  three hundred sixty-five (365) days. A horse shall be presumed eligible if it
				  is a racing breed, at least two (2) years old, and an Indiana bred or sired
				  horse. The owner of such an Indiana bred or sired horse may render the horse
				  ineligible for the testing as described in this rule by indicating in writing
				  the Indiana bred or sired horse is not intended to race in Indiana under
				  subsection (b), provided that the owner of such an Indiana bred or sired horse
				  provides written notice to the office of the commission thirty (30) days before
				  the horse turns two (2) years old or within thirty (30) days after the owner
				  acquires the horse. In this event, the horse shall be deemed ineligible for
				  racing in Indiana as provided for in subsection (b).
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 3 - Split Sample › Section 3-1 - Collection procedures

Current through July 10, 2024
Authority: IC 4-31-3-9
Affected: IC 4-31-12
Sec. 1.
(a) All
				collection procedures shall be done in accordance with chain of custody
				guidelines.
(b) Before sending an
				equine sample to the primary testing laboratory, the official veterinarian or a
				designated commission employee shall divide the specimen into two (2) parts
				provided a sufficient amount is collected.
(c) The official veterinarian or a designated
				commission employee shall attempt to collect a minimum of fifty (50)
				milliliters of urine. A urine specimen shall not be split if less than fifty
				(50) milliliters is collected from the horse. In such instances, the commission
				is entitled to submit the entire urine specimen for testing or detain the horse
				an adequate amount of time until it can be obtained. If an insufficient volume
				of urine is obtained, the trainer and owner are not entitled to a split
				sample.
(d) The official
				veterinarian, a licensed veterinarian authorized by the commission, or a
				veterinary technician under the direct supervision of a commission authorized
				veterinarian shall collect a minimum of thirty (30) milliliters of blood, which
				shall be divided into two (2) portions, one (1) of which shall be forwarded to
				the primary laboratory.
(e) The
				official veterinarian, a licensed veterinarian authorized by the commission, or
				a designated commission employee shall collect a minimum of a hair sample that
				is at least the same size in diameter as a standard pencil. A hair sample shall
				be ineligible for split sample testing.
(f) The official veterinarian or his/her
				designee shall retain the part of the urine and/or blood specimen that is not
				sent to the primary laboratory.
(g)
				If the retained part of a specimen is sent for testing, the official
				veterinarian or designated commission employee shall arrange for the
				transportation of the specimen in a manner that ensures the integrity of the
				sample.
(h) Blood samples shall be
				centrifuged.
(i) The provisions of
				subsections (b), (c), and (d) do not apply to
				71 IAC 8.5-2-5.
Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8.5 - FLAT RACING; HUMAN AND EQUINE HEALTH › Rule 3 - Split Sample › Section 3-2 - Storage and shipment of split samples

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 2.
(a) The
				official veterinarian or his/her designee shall store the retained part of a
				specimen in secure, limited access storage at a site approved by the commission
				for the period required by this section.
(b) If the results of the initial test on a
				specimen are negative, the official veterinarian, or his/her designee, or
				primary laboratory may discard the retained part of the specimen upon receipt
				of the negative result. If the result of the initial test on a specimen is
				positive, the official veterinarian, or his/her designee, or primary laboratory
				may discard the retained part of the specimen after the expiration of the
				period during which an owner or trainer may request the retained part be sent
				for split testing.
(c) The identity
				of the drug or drug metabolites shall be revealed to the split sample
				laboratory. Communication between the primary and split sample laboratory is
				limited to the exchange of the analytical method and the threshold level used
				to confirm the drug's identity.